Medrobotics raises USD 20 million for Flex development
Medrobotics raised USD 20 million from existing investors to develop a next-generation Flex system and pursue additional surgical indications.
Evidence notes
- The company allocated capital to more fully robotic instruments and a next-generation Flex platform.
- Medrobotics also planned regulatory work for uses beyond ear, nose and throat procedures.
- The financing came from existing investors, but the source did not identify a lead investor or individual participants.
Company context
Medrobotics developed the Flex Robotic System, a steerable platform for accessing difficult anatomical locations in minimally invasive procedures. The system combines a flexible robotic scope, visualisation and compatible instruments for surgeon-controlled intervention.